![]() ARIAD Pharmaceuticals ARIAD Pharmaceuticals is a global oncology company focused on discovering, developing and commercializing precision therapies for patients with rare cancers. | ||
Founding Date | Founding Date 2014 | Founding Date 1991 |
Type | Type Public | Type Subsidiary |
Tags | ||
Locations | Locations Sydney, AU HQ Kensington, AU Chuo City, JP Shinjuku City, JP Fort Lee, US | Locations Cambridge, US HQ Boston, US Chicago, US Cincinnati, US Dallas, US Minneapolis, US New York, US see more |
Employees | Employees N/A | Employees 1381% increase |
Financial | ||
Revenue (est.) | Revenue (est.) $638k (FY, 2025) | Revenue (est.) $118.8m (FY, 2015) |
Cost of goods | Cost of goods $159k (FY, 2025) | Cost of goods $2.1m (FY, 2015) |
Gross profit | Gross profit $562k (FY, 2025) | Gross profit $116.7m (FY, 2015) |
Net income | Net income ($4.5m) (FY, 2025) | Net income ($231.2m) (FY, 2015) |

ARIAD Pharmaceuticals is a global oncology company focused on discovering, developing and commercializing precision therapies for patients with rare cancers.
View company